Variables

N (%) or M (±SD)

(N = 102)

Duration of disease

6.8 ± 5.5

General manifestations

49 (48%)

Dermatological manifestations

72 (70.6%)

Facial lesions

49 (48%)

Rheumatological manifestations

66 (64.7%)

Renal manifestations

51 (50%)

Neuropsychic manifestations

10 (9.8%)

Cardiac manifestations

18 (17.6%)

Vascular manifestations

12 (11.8%)

Respiratory manifestations

21 (20.6%)

Digestive manifestations

12 (11.8%)

Ophthalmologic manifestations

25 (24.5%)

Hematological manifestations

28 (27.5%)

Immunological manifestations (n = 80)

39 (48.8%)

Anti-DNA antibodies (n = 83)

39 (47%)

Antinuclear antibodies (n = 84)

17 (20.2%)

Number of manifestations of lupus

4.47 ± 1.95

Type of treatment (n = 99)

Corticosteroid therapy

Anti-malarial

Corticosteroid therapy + anti-malarial

20 (20.2%)

23 (23.2%)

56 (56.6%)

Dose of corticosteroid therapy (n = 76)

≤40 mg

>41 mg

56 (73.7%)

20 (26.3%)